Disinfecting IV catheter caps contain an antiseptic barrier that is expected to provide passive and continuous disinfection of the catheter hub. The addition of this type of device to other elements of catheter maintenance have been examined for its effects on IV catheter-related infections.
Kamboj, M., Blair, R., Bell, N., Son, C., Huang, Y.T., Dowling, M., . . . Sepkowitz, K. (2015). Use of disinfection cap to reduce central-line–associated bloodstream infection and blood culture contamination among hematology-oncology patients. Infection Control and Hospital Epidemiology, 36, 1401–1408.
To evaluate the impact of the routine use of a passive disinfection cap for catheter hub decontamination
Prior to the use of disinfection caps, the organization followed Centers for Disease Control and Prevention (CDC) recommendations for catheter care and routinely used chlorhexidine-impregnated dressings. The intervention was the routine use of disinfection caps with each central venous catheter (CVC) access rather than manual scrubbing of catheter hubs. The caps were changed after each access or every seven days on high-risk units. After implementation on high-risk units for six months, disinfection caps were introduced for routine use in general oncology units. Central line–associated bloodstream infection (CLABSI) rates were compared across all phases, preimplementation to full implementation. Data were compared to that from clinical units that did not use disinfection caps.
No significant decrease in CLABSI rates occurred when disinfection caps were used in high-risk units. CLABSI rates declined significantly when the caps were introduced among general oncology units that were at high-risk (p < 0.001); however, CLABSI rates did not change significantly within general oncology units that were not high-risk. The proportion of contaminated blood cultures from high-risk units declined after introducing the disinfection caps (p < 0.01). Substantial cost savings with reduction in CLABSI rates and contaminated specimens was estimated, assuming hospitalwide implementation results.
The use of catheter disinfection caps may help reduce CLABSI rates in high-risk patient groups and reduce the contamination of blood culture specimens obtained via catheters.
The findings suggest that the routine use of disinfection caps for CVCs may be helpful in reducing CLABSI rates among patients undergoing hematopoietic cell transplantation (HCT) and those with hematologic malignancies deemed to be at high-risk for infection. This is a relatively low-cost intervention that may be beneficial; however, this study does not provide strong evidence in support of this effect. Given the findings here, further research on the effects of this approach is warranted.
Sweet, M.A., Cumpston, A., Briggs, F., Craig, M., & Hamadani, M. (2012). Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. American Journal of Infection Control, 40, 931–934.
The objective of this study was to assess the effect of optimizing hub disinfection using alcohol-impregnated port protectors by measuring the rate of central line-associated bloodstream infections (CLABSIs) and contaminated blood cultures (CBCs) in adult oncologic patient population.
The intervention involved switching traditional catheter hub care using alcohol wipes to care using 70% isopropyl alcohol-impregnated port protectors and needless neutral-pressure connectors. The intervention period results were compared to those from historical controls. Data were collected for all types of central lines, including peripherally inserted tunneled catheters and implanted ports. Line insertion techniques followed best practices for draping, skin prep, etc. Port protectors are luer lock-style caps with provide cleaning as they are twisted on and off catheter hubs. A new protector is used each time the port is accessed. Compliance was assessed by weekly observations defined as percentage of patients with catheter protectors in place.
A single-site inpatient setting in West Virginia
Active antitumor treatment
Observational trial with comparison to historical controls
Observational comparison. Researchers compared CLABSI and CBC rates before and after intervention.
There was a statistically significant decrease in CLABSI rates with the use of alcohol-impregnated port protectors from 2.3 per 1,000 central line days to 0.3 per 1,000 central line days during the intervention period (RR = 0.14, 95% CI [0.02, 1.07], p = 0.03). The rate of contaminated blood cultures decreased from 2.5% to 0.2% (RR = 0.09, 95% CI [0.01, 0.65], p = 0.002).
The use of alcohol-impregnated port protectors may help to reduce CLABSI rates. Further evidence is needed to make strong conclusions.
Suboptimal hub disinfection has a great effect on CLABSI rates. The use of alcohol-impregnated port protectors could help prevent CLABSI by eliminating this factor from the equation; however, effect sizes shown here are small. There are numerous limits to the evidence provided here which reduces the strength of the evidence and any conclusions that can be drawn; however, findings are promising. Additional well-designed studies are warranted. It would be useful to have associated cost benefit analysis, and studies comparing this approach to others to determine most cost-effective approaches to reduce CLABSI risk and rates.